Climate Change Data

Navamedic ASA

Climate Impact & Sustainability Data (2022, 2023)

Reporting Period: 2022

Environmental Metrics

ESG Focus Areas

  • Safe and timely medicine supplies
  • People's health (obesity, antibiotics, medical nutrition)
  • Human and labor rights
  • Work/life balance for employees
  • Employee competence development
  • Supplier sustainability initiatives
  • Packaging waste reduction
  • Sustainable transport
  • Sustainable business travel
  • Environmental Management System (ISO 14001)
  • Business ethics and anti-corruption

Environmental Achievements

  • Improved order handling process to optimize shipments and reduce kilometers driven
  • New travel policy focusing on optimizing business trips and choosing environmentally friendly transportation
  • New company car policy requiring electric or hybrid vehicles where possible
  • ISO 14001 certification (achieved in 2021)

Social Achievements

  • Comprehensive onboarding program for new employees
  • Support for employee skills development
  • Commitment to equal employment opportunities and diversity (19/34 employees are women in 2022)
  • No serious health and safety incidents resulting in injuries or absences in 2022
  • Sick leave rate reduced to 2.0% in 2022 from 5.5% in 2021
  • Obesity treatment support including products, tools, and online resources (MyControl website and MyControl Support program)

Governance Achievements

  • Code of conduct covering business ethics, anti-corruption, working environment, and climate
  • Compliance with EFPIA Disclosure Code
  • Extensive evaluation of suppliers covering anti-corruption and business ethics
  • Launch of Supplier code of conduct in 2023

Climate Goals & Targets

Medium-term Goals:
  • NOK 1 billion revenue company with 15% EBITDA margin
Short-term Goals:
  • At least one product packaging optimization per year

Environmental Challenges

  • Increased competition
  • Supplier out-of-stock situations
  • Price reductions
  • Competition from generic products
  • Increased energy and raw material prices
  • Potential supply chain disruptions due to global market imbalances and instability (e.g., war in Ukraine)
Mitigation Strategies
  • Diversified and broader product portfolio
  • Continuous dialogue with suppliers to ensure favorable terms for agreement renewals
  • Proactive approach to mitigate the impact of increased energy and raw material prices
  • Regular risk assessment (in compliance with Ã…penhetsloven)

Supply Chain Management

Supplier Audits: Extensive evaluation of all suppliers in 2022 covering company and country-specific risks

Responsible Procurement
  • Supplier code of conduct launched in 2023 covering human and labor rights, health & safety, sustainability, anti-bribery, and child labor

Climate-Related Risks & Opportunities

Reporting Period: 2023

Environmental Metrics

Total Carbon Emissions:16.1 + 0.8 + 59.8 + 9.8 + 68.2 = 154.7 tCO2e/year
Scope 1 Emissions:16.1 tCO2e/year
Scope 2 Emissions:0.8 tCO2e/year
Scope 3 Emissions:137.8 tCO2e/year
Carbon Intensity:0.3 tCO2e per mNOK revenue

ESG Focus Areas

  • Sustainable supply of medicines
  • Public health (obesity, antibiotics, medical nutrition)
  • Human and labor rights
  • Employee well-being and development
  • Sustainable supply chain
  • Packaging waste reduction
  • Sustainable transportation
  • Environmental management (ISO 14001)
  • Corporate social responsibility
  • Ethical conduct and compliance
  • Sustainable sourcing

Environmental Achievements

  • Implemented robust methodologies to quantify environmental footprint using World Favor, covering Scope 1, 2, and 3 emissions.
  • Optimized product transportation through warehouse consolidation, reducing kilometers traveled.
  • Removed excess plastic and reduced packaging size for some products.
  • Joined the Science Based Targets initiative.

Social Achievements

  • Launched Lighter Together weight management program.
  • Created MyControl website to increase public knowledge about obesity.
  • Collaborated with five pharmaceutical companies to engage pharmacy employees and gather patient insights.
  • Maintained a diverse workforce (26 women out of 44 employees in 2023).

Governance Achievements

  • Launched a Supplier Code of Conduct.
  • Implemented World Favor to distribute sustainability questionnaires to partners.
  • Adheres to the EFPIA Disclosure Code.
  • Maintains a zero-tolerance policy towards corruption.

Climate Goals & Targets

Long-term Goals:
  • Continue with packaging optimization (removing unnecessary material, support recycling and use of recyclable materials)
  • Continue developing and maintain a robust methodology and system for CO2 emission monitoring
Medium-term Goals:
  • Climate neutral business trips by 2030
  • All company cars to be electric
Short-term Goals:
  • Continuous partners evaluation and follow-up on their sustainable business practice

Environmental Challenges

  • Reducing environmental footprint across the supply chain.
  • Ensuring sustainable practices among suppliers.
Mitigation Strategies
  • Warehouse consolidation to optimize transportation.
  • Packaging optimization to reduce waste.
  • Supplier Code of Conduct and sustainability questionnaires.
  • Collaboration with suppliers and customers for efficient logistics.

Supply Chain Management

Responsible Procurement
  • Supplier Code of Conduct
  • Sustainability questionnaires through World Favor

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: UN Sustainable Development Goals (SDGs), Science Based Targets initiative

Certifications: ISO 14001